Submit Your Abstract - Abstract Submissions Are Closed

Late-Breaking Abstract Submissions
The following submissions have been accepted for Oral Presentation, and email notifications have been sent:

#439 Differences in Psychometric Properties of Clinician and Patient-reported Outcome Measures for Atopic Dermatitis By Race and Skin Tone: A Systematic Review
#440 COVID-19 in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: case series from the ECZTEND long-term extension trial
#447 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two Phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)
#463 MOSAIC: Monitoring of Scratch via Accelerometry in Children with Atopic Dermatitis
#465 Incidence of bacterial and non-bacterial conjunctivitis in patients with atopic dermatitis treated with dupilumab: a US multi-database cohort study
#466 Long-term efficacy of baricitinib 2-mg for the treatment of atopic dermatitis in North America
#494 Financial Burden and Impact of Atopic Dermatitis Out-Of-Pocket Healthcare Expenses Among Black Individuals in the United States
#504 Skindex-Mini Performance in Pediatric Patients with Atopic Dermatitis
#505 Comparison of Efficacy of Targeted Therapies without Topical Corticosteroids for Moderate to severe Atopic Dermatitis: Systematic Review and Network Meta-analysis
#506 Achieving Incrementally Greater Skin Improvement Thresholds with Upadacitinib in Moderate to Severe Atopic Dermatitis: A Pooled Analysis of Two Phase 3 Studies (Measure Up 1 and Measure Up 2)
#511 Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
#516 Efficacy of Abrocitinib Monotherapy for the Treatment of Moderate-to-Severe Atopic Dermatitis by Race
#521 Interpreting the Relationship Between Pruritus and Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-1 and MONO-2
#526 Patient Perspectives of Atopic Dermatitis: Comparative Social Media and Scientific Literature Analysis
#537 Quality of life in patients with AD in Argentina. A web-based survey of 1650 adults and children with AD conducted by two patient associations
© 2021 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.